A Study of a Vaccine in Combination With Beta-glucan in People With Neuroblastoma
Clinical trial NCT06057948 · RECRUITING
Trial details
- NCT number
- NCT06057948
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-09-21
- Primary completion
- 2027-03-21
- Enrollment
- 94
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.